Faeth Therapeutics, Inc. (FTH)
NASDAQ: FTH · Real-Time Price · USD
19.99
+0.34 (1.73%)
At close: Nov 4, 2026, 4:00 PM EST
19.90
-0.09 (-0.45%)
After-hours: Nov 4, 2026, 7:30 PM EST
Faeth Therapeutics Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Faeth Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $55.31. The average 1-year stock price forecast is 176.69% higher than the current stock price, while the lowest is $40 (+100.10%) and the highest is $69 (+245.17%).
Price Target: $55.31 (+176.69%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Faeth Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 8 | 9 | 11 | 12 | 12 |
| Buy | 0 | 2 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 10 | 12 | 14 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $60 | Buy | Reiterates | $60 | +200.15% | Nov 4, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $70 → $69 | Buy | Reiterates | $70 → $69 | +245.17% | Nov 4, 2026 |
| JonesTrading | JonesTrading | Buy Maintains $55 | Buy | Maintains | $55 | +175.14% | Nov 3, 2026 |
| BTIG | BTIG | Buy Reiterates $55 | Buy | Reiterates | $55 | +175.14% | Oct 27, 2026 |
| Citi | Citi | Buy Maintains $55 | Buy | Maintains | $55 | +175.14% | Oct 16, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-15.60
EPS Next Year
-3.67
from -15.60
EPS and Forward PE are based on non-GAAP adjusted numbers.